MeAgain offers five food logging methods photo, barcode, voice, search, and quick-add so the app can fit the day you are actually having
The FDA approved Wegovy in 2021 after clinical trials demonstrated that patients using semaglutide lost an average of 15% of body weight over 68 weeks
Anxiety and GLP-1 Use: What Clinical Evidence Shows Large-scale trials of semaglutide, including the SUSTAIN and STEP series, monitored mood and psychiatric adverse events as secondary outcomes
The WADA exception and competitive sports testing Here is where the picture becomes meaningfully more complex
Best-documented routes: IV (strongest evidence, fastest onset), followed by injectable and liposomal oral
Unanticipated Residual Gastric Contents in an Appropriately Fasted Pediatric Patient on Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Case Report and Review of Perioperative Considerations